The membrane and lipids as integral participants in signal transduction: Lipid signal transduction for the non-lipid biochemist

American Journal of Physiology - Advances in Physiology Education

Volumn 31, Issue 1, 2007, Pages 5-16

  Eyster, Kathleen M ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Ceramide; Fatty acid; Lysophospholipid; Phosphatidylinositol; Phospholipase; Sphingomyelin

Indexed keywords

EID: 33847378878     PISSN: 10434046     EISSN: 15221229     Source Type: Journal    
DOI: 10.1152/advan.00088.2006     Document Type: Review

References (95)

1. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev 81: 1269-1304, 2001.
2. Baumruker T, Bornancin F, Billich A. The role of sphingosine and ceramide kinases in inflammatory responses. Immunol Lett 96: 175-185, 2005.
3. Benzaria A, Meskini N, Dubois M, Croset M, Nemoz G, Lagarde M, Prigent AF. Effect of dietary argan oil on fatty acid composition, proliferation, and phospholipase D activity of rat thymocytes. Nutrition 22: 628-637, 2006.
4. Berridge MJ. Unlocking the secrets of cell signaling. Annu Rev Physiol 67: 1-21, 2005.
5. Bütikofer P, Lin ZW, Chiu DTY, Lubin B, Kuypers FA. Transbilayer distribution and mobility of phosphatidylinositol in human red blood cells. J Biol Chem 265: 16035-16038, 1990.
6. Cantley LC. The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002.
7. Carpenter G, Ji Q. Phospholipase C-gamma as a signal transducing element. Exp Cell Res 253: 15-24, 1999.
8. Chakraborti S. Phospholipase A2 isoforms: a perspective. Cell Signal 15: 637-665, 2003.
9. Chalfant CE, Szulc Z, Roddy P, Bielawska A, Hannun YA. The structural requirements for ceramide activation of serine-threonine protein phosphatases. J Lipid Res 45: 496-506, 2004.
10. Chalfant CE, Spiegel S. Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 118: 4605-4612, 2005.
11. Chan TO, Rittenhouse SE, Tsichlis PN. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68: 965-1014, 1999.
12. Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 292: 617-629, 1993.
13. Cherr GN, Yudin AI, Overstreet JW. The dual functions of GPI-anchored PH-20: hyaluronidase and intracellular signaling. Matrix Biol 20: 515-525, 2001.
14. Chou MM, Hou W, Johnson J, Graham LK, Lee MH, Chen CS, Newton AC, Schaffhausen BS, Toker A. Regulation of protein kinase Cδ by PI 3-kinase and PDK-1. Curr Biol 8: 1069-1077, 1998.
15. Cremesti AE, Goni FM, Kolesnick R. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett 531: 47-53, 2002.
16. Cuvillier O. Sphingosine in apoptosis signaling. Biochim Biophys Acta 1585: 153-162, 2002.
17. Di Paolo G, Di Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 443: 651-657, 2006.
18. Downes CP, Gray A, Lucocq JM. Probing phosphoinositide functions in signaling and membrane trafficking. Trends Cell Biol 15: 259-268, 2005.
19. Endemann G, Yonezawa K, Roth RA. Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. J Biol Chem 265: 396-400, 1990.
20. Espey LL. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 50: 233-238, 1994.
21. Exton JH. Regulation of phospholipase D. FEBS Lett 531: 58-61, 2002.
22. Eyster KM. Introduction to signal transduction: a primer for untangling the web of intracellular messengers. Biochem Pharmacol 55: 1927-1938, 1998.
23. Fang X, Gaudette D, Furui T, Mao M, Estrella V, Eder A, Pustilnik T, Sasagawa T, Lapushin R, Yu S, Jaffe RB, Wiener JR, Erickson JR, Mills GB. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann NY Acad Sci 905: 188-208, 2000.
24. Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, Moore DD. Androstane metabolites bind to and deactivate the nuclear receptor CAR-β. Nature 395: 612-615, 1998.
25. Foster DA, Xu L. Phospholipase D in cell proliferation and cancer. Molec Canc Res 1: 789-800, 2003.
26. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875, 2001.
27. Goetzl EJ, An S, Smith WL. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J 9: 1051-1058, 1995.
28. Haag M, Dippenaar NG. Dietary fats, fatty acids and insulin resistance: short review of a multifaceted connection. Med Sci Monit 11: RA359-RA367, 2005.
29. Hannun YA, Loomis CR, Merrill AH Jr, Bell RM. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and human platelets. J Biol Chem 261: 12604-12609, 1986.
30. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science 274: 1855-1859, 1996.
31. Hannun YA, Obeid LM. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277: 25847-25850, 2002.
32. Hirano Y, Yoshinaga S, Ogura K, Yokochi M, Noda Y, Sumimoto H, Inagaki F. Solution structure of atypical protein kinase C PB1 domain and its mode of interaction with ZIP/p62 and MEK5. J Biol Chem 279: 31883-31890, 2004.
33. Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ. Lysophospholipidsreceptor revelations. Science 294: 1875-1878, 2001.
34. Ingham PW. Hedgehog signaling: a tale of two lipids. Science 294: 1879-1881, 2001.
35. Imig JD. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am J Physiol Renal Physiol 289: R496-R503, 2005.
36. Jenkins GM, Frohman MA. Phospholipase D: a lipid centric review. Cell Mol Life Sci 62: 2305-2316, 2005.
37. Jump DB. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 41: 41-78, 2004.
38. Kashiwagi K, Shirai Y, Kuriyama M, Sakai N, Saito N. Importance of C1B domain for lipid messenger-induced targeting of protein kinase C. J Biol Chem 277: 18037-18045, 2002.
39. Kishimoto A, Takai Y, Mori T, Kikkawa U, Nishizuka Y. Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J Biol Chem 255: 2273-2276, 1980.
40. Kolesnick RN, Krönke M. Regulation of ceramide production and apoptosis. Annu Rev Physiol 60: 643-665, 1998.
41. Kolesnick R. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110: 3-8, 2002.
42. Kostenis E. Novel clusters of receptors for sphingosine-1- phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands. J Cell Biochem 92: 923-936, 2004.
43. Kostenis E. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands. Pharmacol Ther 102: 243-257, 2004.
44. Kuwata H, Yamamoto S, Takekura A, Murakami M, Kudo I. Group IIA secretory phospholipase A2 is a unique 12/15-lipoxygenase-regulated gene in cytokine-stimulated rat fibroblastic 3Y1 cells. Biochim Biophys Acta 1686: 15-23, 2004.
45. Leevers SJ, Vanhaesebroeck B, Waterfield MD. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol 11: 219-225, 1999.
46. Leslie NR, Downes CP. PTEN: the down side of PI 3-kinase signalling. Cell Signal 14: 285-295, 2002.
47. Lim H, Dey SK. Minireview: a novel pathway of prostacyclin signaling-hanging out with nuclear receptors. Endocrinology 143: 3207-3210, 2002.
48. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269-278, 1993.
49. Marchesini N, Hannun YA. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem Cell Biol 82: 27-44, 2004.
50. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J 332: 281-292, 1998.
51. Meyer zu Heringdorf D, Himmel HM, Jakobs KH. Sphingosylphosphorylcholine-biological functions and mechanisms of action. Biochim Biophys Acta 1582: 178-189, 2002.
52. Mumby SM. Reversible palmitoylation of signaling proteins. Curr Opin Cell Biol 9: 148-154, 1997.
53. Murakami M, Kudo I. Phospholipase A2. J Biochem 131: 285-292, 2002.
54. Murphy GJ, Holder JC. PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharm Sci 21: 469-474, 2000.
55. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
56. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 55: 69-102, 1986.
57. Neer EJ. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80: 249-257, 1995.
58. Newton AC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J 370: 361-371, 2003.
59. Nusse R. Wnts and hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface. Development 130: 5297-5305, 2003.
60. O'Keefe JH Jr, Harris WS. From Inuit to implementation: omega-3 fatty acids come of age. Mayo Clin Proc 75: 607-614, 2000.
61. Owen JS, Baker PRS, O'Flaherty JT, Thomas MJ, Samuel MP, Wooten RE, Wykle RL. Stress-induced platelet-activating factor synthesis in human neutrophils. Biochim Biophys Acta 1733: 120-129, 2005.
62. Parker PJ, Murray-Rust J. PKC at a glance. J Cell Sci 117: 131-132, 2004.
63. Pietras RJ, Szego CM. Endometrial cell calcium and oestrogen action. Nature 253: 357-359, 1975.
64. Pietras RJ, Szego CM. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265: 69-72, 1977.
65. Pike LJ. Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochim Biophys Acta 1746: 260-273, 2005.
66. Piomelli D. Arachidonic acid in cell signaling. Curr Opin Cell Biol 5: 274-280, 1993.
67. Poff CD, Balazy M. Drugs that target lipoxygenases and leukotrienes as emerging therapies for asthma and cancer. Curr Drug Targets Inflamm Allergy 3: 19-33, 2004.
68. Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69: 419-445, 2000.
69. Prokazova NV, Zvezdina ND, Korotaeva AA. Review: effect of lysophosphatidylcholine on transmembrane signal transduction. Biochem (Mosc) 63: 31-37, 1998.
70. Rebecchi MJ, Scarlata S. Pleckstrin homology domains: a common fold with diverse functions. Annu Rev Biophys Biomol Struct 27: 503-528, 1998.
71. Ruvolo PP. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharm Res 47: 383-392, 2003.
72. Saltiel AR, Pessin JE. Insulin signaling pathways in time and space. Trends Cell Biol 12: 65-71, 2002.
73. Sawai H, Domae N, Okazaki T. Current status and perspectives in ceramide-targeting molecular medicine. Curr Pharm Design 11: 2479-2487, 2005.
74. Scheid MP, Woodgett JR. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett 546: 108-112, 2003.
75. Sharom FJ, Lehto MT. Glycosylphosphatidylinositol-anchored proteins: structure, function, and cleavage by phosphatidylinositol-specific phospholipase C. Biochem Cell Biol 80: 535-549, 2002.
76. 4 isomerase gene family. Endocr Rev 26: 525-582, 2005.
77. Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 86: 266-275, 2001.
78. 2+ signalling. Trends Pharm Sci 22: 459-464, 2001.
79. Spector AA, Fang X, Snyder GD, Weintraub NL. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 43: 55-90, 2004.
80. Stulnig TM. Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol 132: 310-321, 2003.
81. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 81: 153-208, 2001.
82. Takai Y, Kishimoto A, Iwasa Y, Kawahara Y, Mori T, Nishizuka Y. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem 254: 3692-3695, 1979.
83. Tsui-Pierchala BA, Encinas M, Milbrandt J, Johnson EM Jr. Lipid rafts in neuronal signaling and function. Trends Neurosci 25: 412-417, 2002.
84. Vanhaesebroeck B, Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253: 239-254, 1999.
85. Walters MR, Nemere I. Receptors for steroid hormones: membrane-associated and nuclear forms. Cell Mol Life Sci 61: 2309-2321, 2004.
86. Wang D, Mann JR, Dubois RN. The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 128: 1445-1461, 2005.
87. Wang HB, Kazanietz MG. Chimaerins, novel non-protein kinase C phorbol ester receptors, associate with Tmp21-I (p23). Evidence for a novel anchoring mechanism involving the chimaerin C1 domain. J Biol Chem 277: 4541-4550, 2002.
88. Wehling M. Specific, non-genomic actions of steroid hormones. Annu Rev Physiol 59: 365-393, 1997.
89. Wishart MJ, Taylor GS, Slama JT, Dixon JE. PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench. Curr Opin Cell Biol 13: 172-181, 2001.
90. Wymann MP, Zvelebil M, Laffargue M. Phosphoinositide 3-kinase signalling-which way to target? Trends Pharm Sci 24: 366-376, 2003.
91. Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta 1582: 81-88, 2002.
92. Yaqoob P. Fatty acids as gatekeepers of immune cell regulation. Tr Immunol 24: 639-645, 2003.
93. Yart A, Chap H, Raynal P. Phosphoinositide 3-kinases in lysophosphatidic acid signaling: regulation and cross-talk with the ras/mitogen-activated protein kinase pathway. Biochim Biophys Acta 1582: 107-111, 2002.
94. Yoshikai Y. Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection. Curr Opin Infect Dis 14: 257-263, 2001.
95. Yoshinaga S, Kohjima M, Ogura K, Yokochi M, Takeya R, Ito T, Sumimoto H, Inagaki F. The PB1 domain and the PC motif-containing region are structurally similar protein binding modules. EMBO J 22: 4888-4897, 2003.